nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Aurobindo Pharma Limited (NSE India Code : AUROPHARMA) BUY

Company Name :

Enter Company Name or NSE Code

AUROPHARMA Technical Levels

Resistance 2		165.78
Resistance 1		156.12
PIVOT		150.33
Support 1		140.67
Support 2		125.22

AUROPHARMA Fundamentals

Earning Growth		-99.99%
Profit Margin		6.07
PE		1.59
EPS		63.73
Quarter		30-Sep-11

AUROPHARMA Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size		2000

AUROPHARMA Options

Most Active Call		140
Most Active Put		140
Highest OI Call		150
Highest OI Put		130
Expiry Date		19-Oct-12

AUROPHARMA Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

AUROPHARMA Share Price on 5-10-2012

Open		140
High		143.85
Low		136.1
Close		138.6
Volume		2014008
Change		-6.1 (-4.22%)

Series		EQ
Date of Listing		19-Jul-00
Paid Up Value		1
Face Value		1
Market Capital		1825.48 Crores
52 Week High/Low		160 / 80.15

Sponsored Advertisement

Aurobindo Pharma Limited Company Profile

Aurobindo Pharma (AUROBINDOP) was founded in 1986 by P.V.Ramaprasad Reddy, K.Nityananda Reddy and a small, highly committed set of professionals, the company became a public venture in 1992. It commenced operations in 1988-89 with a single unit manufacturing semi synthetic penicillins (SSPs) at Pondicherry. Aurobindo Pharma is a fast-track integrated pharmaceutical company headquartered in Hyderabad, India, producing and marketing active pharmaceutical ingredients (bulk actives), intermediates and specialty generic formulations. AUROBINDOP ranks among the top five pharma companies in India and is a multi product, multi technology, transnational company. The company`s products serve consumers in India and over 100 other countries including the markets of United States and Europe. Aurobindo Pharma is an R&D driven chemistry business house with a very broad product portfolio. The company has a presence in fast growing life style disease drugs, anti infective drugs, and key specialty therapeutics. Aurobindo Pharma is a known leader in the semi synthetic penicillin and cephalosporin. After creating a name for it in producing APIs and intermediates, the company sees major growth in its specialty generic formulations business. In December 29, 2006, Agile Pharma B.V., the ultimate subsidiary of AUROBINDOP acquired 100% stake in the share capital of Pharmacin International B.V., The Netherlands AUROBINDOP sees its potential both in regulated and other global markets. In regulated markets, Aurobindo Pharma visualises profits aided by the thrust in building intellectual property. In the large growth segments of other global markets, it will succeed by virtue of its cost-efficient production. The company is based at Hyderabad, India.

AUROPHARMA Intraday Realtime Chart

AUROPHARMA Corporate Announcements

DATE	PURPOSE
06-Aug-12	Press Release
02-Aug-12	Disclosure under SEBI Takeover Regulations
30-Jul-12	Disclosure under SEBI Takeover Regulations
26-Jul-12	Disclosure under SEBI Takeover Regulations
24-Jul-12	Disclosure under SEBI Takeover Regulations

AUROPHARMA Corporate Actions

DATE	PURPOSE
30-Jul-12	Annual General Meeting And Dividend - Re.1/- Per Share
30-Jul-12	AGM/DIV-RE.1/- PER SHARE
20-Jul-11	Annual General Meeting And Dividend Re.1/- Per Share
20-Jul-11	AGM/DIV-RE.1/- PER SHARE
10-Feb-11	Face Value Split From Rs.5/- To Re.1/-

AUROPHARMA Board Meetings

MEETING DATE	PURPOSE
29-May-12	Audited Financial Results
29-May-12	Results/Dividend
13-Feb-12	Board Meeting Postponed
10-Feb-12	Un-audited Financial Results
08-Nov-11	Un-audited Financial Results

AUROPHARMA Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

In case of purchase of shares, when do I make payment to the broker?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer